Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO - Get Free Report)'s stock price passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.28 and traded as low as $0.24. Northwest Biotherapeutics shares last traded at $0.24, with a volume of 2,251,472 shares trading hands.
Northwest Biotherapeutics Price Performance
The company has a market cap of $338.81 million, a price-to-earnings ratio of -3.07 and a beta of -0.52. The company's 50-day simple moving average is $0.27 and its 200-day simple moving average is $0.28.
About Northwest Biotherapeutics
(
Get Free Report)
Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer.
Featured Articles
Before you consider Northwest Biotherapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Northwest Biotherapeutics wasn't on the list.
While Northwest Biotherapeutics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
